Myotonic Potentials in the Myopathy Induced by HMG-CoA Reductase Inhibitor
Journal of the Korean Neurological Association
; : 186-189, 2014.
Article
en Ko
| WPRIM
| ID: wpr-27580
Biblioteca responsable:
WPRO
ABSTRACT
HMG-CoA reductase inhibitor is widely used for the treatment of dyslipidemia, and for the prevention of stroke and cardiovascular disease. However, it is necessary to consider the adverse effects associated with this drug. Myopathy is a well-known side effect of statin therapy, but myotonic potentials in cases with statin myopathy have thus far been reported only rarely. We report four cases of myopathy with myotonic potentials on electromyography after multidrug administration. All of the patients recovered shortly after statin withdrawal.
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Oxidorreductasas
/
Enfermedades Cardiovasculares
/
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Accidente Cerebrovascular
/
Electromiografía
/
Dislipidemias
/
Enfermedades Musculares
Límite:
Humans
Idioma:
Ko
Revista:
Journal of the Korean Neurological Association
Año:
2014
Tipo del documento:
Article